GLP-1 Medications and Muscle Loss: What the Research Actually Shows

GLP-1 medications — semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) among them — have changed the conversation around weight loss faster than almost anything I've seen in my career. I have clients on them, friends on them, and a steady stream of questions in my inbox about them.

The question I get most isn't whether they work for weight loss — the data on that is clear. It's this one: "Am I losing muscle, not just fat?" It's a legitimate concern, and the research actually has a fair amount to say about it.

What the Research Actually Shows

The short answer: yes, a meaningful share of the weight lost on GLP-1 medications is lean mass, not just fat. In the STEP 1 trial of semaglutide and the SURMOUNT-1 trial of tirzepatide — the major clinical trials behind these medications — lean mass loss accounted for roughly a third to just under half of total weight lost (Circulation, AHA). A separate systematic review and meta-analysis across multiple trials put the figure closer to 25% of total weight lost (ScienceDirect), while other reviews cite a broader range of roughly 25–40% (Mayo Clinic, PMC case series).

Worth noting: "lean mass" on these scans isn't purely skeletal muscle — it also includes organs, bone, and body water, so not every pound of lean mass lost is a pound of muscle specifically (PMC).

Context That Actually Matters

This isn't unique to GLP-1 medications. Any method of significant weight loss — calorie restriction, bariatric surgery, other weight-loss medications — comes with some degree of lean mass loss (Circulation, AHA). The concern with GLP-1s is less that they're uniquely damaging to muscle and more that weight loss happens faster and goes further than most people have experienced before, making the lean mass loss more noticeable in absolute terms.

There's also a nuance that tends to get lost in the headlines: at least one meta-analysis found that while absolute lean mass did decrease, the relative proportion of lean mass to total body weight was largely unchanged — meaning body composition as a percentage held fairly steady even as the numbers on both sides of the equation went down (ScienceDirect). That's a meaningfully different story than "this medication is eating your muscle."

What Actually Helps

The consistent thread across the research: resistance training and adequate protein intake are the two levers that matter most for preserving lean mass during GLP-1 therapy, even though dedicated long-term trials in this exact population are still catching up (PubMed). Recommendations converge around protein intakes above roughly 1.2 grams per kilogram of body weight per day, spread evenly across meals, paired with structured resistance training two to five days a week (ScienceDirect, PMC).

One recent study following adults combining GLP-1 therapy with resistance training and individualized protein targets found participants lost about 13% of body weight but only around 3% of muscle mass over six months — a very different ratio than the 25–40% lean-mass figures cited earlier (David Protein). That gap is the whole point: the medication drives the calorie deficit, but what you eat and how you move largely determine what kind of weight comes off.

My Honest Take

I don't manage GLP-1 prescriptions — that stays with your prescribing provider, and it should. What I do is the part that often gets the least airtime in a fifteen-minute follow-up: building the protein targets, meal structure, and resistance-training foundation that determine whether the weight you lose is mostly fat or a real mix of fat and muscle.

If you're on one of these medications, or considering one, and you want a plan for the nutrition and strength side of it — not a second opinion on the medication itself — that's exactly the kind of thing we can map out together.

Book a Complimentary Clarity Call to get started. And if you don't see a time on the calendar that works for you, email me directly at support@thrive-functional.com — I often have additional availability that isn't listed there.

In health,

Silvanna, MS, CFNC